{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T12:38:13Z","timestamp":1717763893831},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamadermatol.2021.5342","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T16:04:11Z","timestamp":1645027451000},"page":"354","source":"Crossref","is-referenced-by-count":1,"title":["Ichthyosis Scoring System\u2014A Powerful Tool in the Era of Immune Pathway\u2013Targeted Therapies for Ichthyosis"],"prefix":"10.1001","volume":"158","author":[{"given":"Masashi","family":"Akiyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"3","key":"ded210024r1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jde.2016.43.issue-3","article-title":"Inherited ichthyosis: non-syndromic forms.","volume":"43","author":"Takeichi","year":"2016","journal-title":"J Dermatol"},{"issue":"7","key":"ded210024r2","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3433","article-title":"Ichthyosis: a road model for skin research.","volume":"100","author":"Vahlquist","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"ded210024r3","article-title":"The genomic and phenotypic landscape of ichthyosis: an analysis of 1000 kindreds.","author":"Sun","journal-title":"JAMA Dermatol"},{"issue":"2","key":"ded210024r4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/pde.2010.27.issue-2","article-title":"Reliable methods to evaluate the clinical severity of ichthyosis.","volume":"27","author":"Kamalpour","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"ded210024r5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jid.2017.04.037","article-title":"Establishing and validating an ichthyosis severity index.","volume":"137","author":"Marukian","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ded210024r6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/bjd.2011.165.issue-5","article-title":"Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis.","volume":"165","author":"Bodemer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"ded210024r7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"ded210024r8","article-title":"Development and initial validation of a novel system to assess ichthyosis severity.","author":"Sun","journal-title":"JAMA Dermatol"},{"issue":"7","key":"ded210024r9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/febs.v288.7","article-title":"Acylceramide is a key player in skin barrier function: insight into the molecular mechanisms of skin barrier formation and ichthyosis pathogenesis.","volume":"288","author":"Akiyama","year":"2021","journal-title":"FEBS J"},{"issue":"2","key":"ded210024r10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","article-title":"Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature.","volume":"143","author":"Malik","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"ded210024r11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/jamadermatol.2020.1018","article-title":"Pathogenesis-based therapy with repurposed biologics for monogenic inflammatory skin disorders.","volume":"156","author":"Paller","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"ded210024r12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jid.2018.08.027","article-title":"Profiling immune expression to consider repurposing therapeutics for the ichthyoses.","volume":"139","author":"Paller","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"8","key":"ded210024r13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome.","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"ded210024r14","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1172\/JCI132987","article-title":"3D model of harlequin ichthyosis reveals inflammatory therapeutic targets.","volume":"130","author":"Enjalbert","year":"2020","journal-title":"J Clin Invest"},{"key":"ded210024r15","unstructured":"Paller? A. The efficacy and safety of secukinumab in patients with ichthyoses. Accessed November 5, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03041038"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2788837\/jamadermatology_akiyama_2022_ed_210024_1649281923.14069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T15:02:24Z","timestamp":1650466944000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2788837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.5342","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}